News-Medical.Net on MSN
UVA researcher wins $700,000 for promising ovarian cancer research
Promising ovarian cancer research by Melanie Rutkowski, PhD, at the University of Virginia Comprehensive Cancer Center has ...
A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the current gold standard. This research, ...
CLEVELAND, Ohio (June 11, 2025)—Nomograms have a strong reputation as reliable predictive models that simplify statistical prediction models and guide personalized treatment to formulate preventive ...
A sponge-like gold nanoparticle platform could deliver faster, more accurate, and less invasive ovarian cancer diagnostics.
Clinical Trials Arena on MSN
BioInvent’s mAb plus Keytruda boosts ORR in mid-stage ovarian cancer trial
Treatment with the tumour necrosis factor receptor 2 (TNFR2)-targeting monoclonal antibody (mAb) plus Keytruda was also found ...
NICE has proposed age-based CA125 thresholds to improve early ovarian cancer detection while reducing unnecessary scans in ...
Andrews, a renowned matchmaker, has passed away at 56 after battling stage 4 ovarian cancer. Diagnosed in 2017, the cancer ...
News-Medical.Net on MSN
Dihydrotanshinone I induces autophagic cell death in ovarian cancer
A recent study published in Engineering has shed light on the potential therapeutic effects of dihydrotanshinone I (DHT), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback